Advances in PCR for POCT to Address the Sexually Transmitted Infection Epidemic
You already have access to this webinar replay.
Please complete the following to have access to the full webinar:
Gary Schoolnik, MD
Chief Medical Officer,
In this on-demand video, infectious disease expert Gary Schoolnik, MD will present recent advances in nucleic acid amplification testing (NAAT) methodology, and instrument-free single-use PCR (polymerase chain reaction) in particular, that provides both accuracy and speed of results at the point of care. Such advancements for STI enables clinicians to make results-driven diagnoses for correct treatment, all while the patient is till at the clinic visit, for a more focused clinician-patient dialogue and teachable moment.
In this video, participants will:
- Review the rising rates of Sexually Transmitted Infections (STI)
- Analyze today’s STI testing methods
- Discuss the challenges and implications of today’s testing methods: for the patient, clinician, and public health.
- Examine the criteria for POC testing that could improve patient and clinician satisfaction scores and positively impact STI rates.
- Video recording replay
- Presentation Slides (PDF)
About the Presenter
Dr. Gary Schoolnik is Chief Medical Officer, Visby Medical. He is also Professor of Medicine (emeritus), Stanford Medical School, Attending Physician in Internal Medicine and Infectious Diseases at Stanford University Hospital and Associate Director of Stanford’s Institute for Immunology, Transplantation and Infection.
Dr. Schoolnik received his M.D. degree and infectious diseases subspecialty training at the University of Washington in Seattle, served as medical intern, resident and chief resident at Harvard’s Massachusetts General Hospital in Boston and he was a research associate and associate physician at the Rockefeller University in Manhattan. While on the Stanford Medical School faculty he served as Chief of the Division of Infectious Diseases and Geographic Medicine. National service included his appointment to the Advisory Council of the National Institutes of Allergy and Infectious Diseases of the NIH and his role as chair of the NIH Trans-Institute Committee on the Human Microbiome and co-chair of the NIH Blue Ribbon Committee on Bioterrorism. International consultative activities include the Board of Scientific Counselors of Fudan University in Shanghai. He was founding editor of the journal Molecular Microbiology and Associate Editor of the Journal of Clinical Investigation.
His academic research focuses on the molecular, genetic and genomic aspects of infectious agents and on the development of new drugs, vaccines and diagnostics. Gary has 6 issued patents.
Full lists of publications: visit https://profiles.stanford.edu/gary-schoolnik